Tuesday, August 4, 2026

Narketpally syn local CBBLE: Participatory medical cognition (August 2026)

                                            

[3.00 pm, 8/3/2026] cm: OPD today.
Young man with scleroderma, cutaneous vasculitic ulcers, digital infarcts, with spondyloarthropathy, severely reduced chest expansion of 1 cm with Schobers not done, reduced cervical spine mobility suggestive of OPLL
                                                     

           

[9.41 pm, 8/3/2026] cm: Next patient had just low backache and while the schobers was forgotten in the previous patient where it was more likely to be positive, this image turned out to be a good demonstration of the elemental landmarks , bilateral si joint dimples and measurements that can be archived
                                    
                                

                                
[10.22 am, 8/4/2026] cm: OPD now
Metabolic syn with sensory ataxia
                
[11.34 am, 8/4/2026] cm: PUO and sensory ataxia Admitted in the medicine ward from OPD right now. Nice pleural rub on auscultation other than wheeze.
[6:39 am, 05/08/2026] cm: This sounds like a clarion call for over-testing as clinical examination findings appear to be done away with before moving from history to testing straight away?
To quote,
"an autonomous artificial intelligence agent operating in a sandboxed EHR environment, can navigate a large clinical action space to obtain patient histories; order and interpret laboratory, imaging and microbiology tests;"
Or perhaps one needs to redefine clinical examination also as testing as in testing the ankle reflexes, testing the breath sounds, testing the palpability of potentially enlarged organs etc
[2:32 pm, 05/08/2026] huai147: Sir .. will human beings like to avoid a human interface altogether?  surreal ..
[7:09 pm, 07/08/2026] huai54: Transforming Clinical Reasoning: Welcome to Vibe Rounds
​What if AI in medical education didn't just give you the answers, but taught you how to think like an expert clinician?
​Vibe Rounds is a Socratic AI framework built for clinical training. Try now - https://viberounds.ai.studio/
Contact on WhatsApp if any assistance needed -
+9779817599973
+917318510434
[7:43 pm, 07/08/2026] huai54: https://youtu.be/bhdh5o9XJao?si=i75SfcftyVjD83Gv
[9:49 am, 09/08/2026] cm: Dear @all, good morning.I’ve recently launched this channel The MBBS Blueprint | A Backbencher's Guide dedicated to simplify clinical medical education for MBBS undergraduates. My goal is to make complex clinical concepts easier to grasp and help with exam prep. I would be really grateful if you could share the channel link with your students, or forward it to any relevant academic WhatsApp groups.
Thank you so much for your time and support.Chanukya
[9:49 am, 09/08/2026] cm: This channel is for those who are just like me in my MBBS days,  who are sitting in back rows of classes, getting bored and easily distracted and lost !
​Back in my MBBS days, I was a proud backbencher. I struggled to connect the dots and  wished for a teacher who could just break down complex clinical concepts into plain, simple language. Since I couldn't find that teacher except at PGI, Chandigarh where i went on to did DM Endocrinology,I finally  decided to become one after working at few corporates with DNB programs, NIMS, Hyderabad,and private medical colleges, especially after watching how teaching got transformed over years.
​This channel is dedicated to simplifying clinical medicine for undergraduates and NEET PG aspirants. No heavy jargon, no intimidation: just clear, visual, and practical explanations designed to help  understand the subject easily, no matter where one sits in the classroom!
[9:49 am, 09/08/2026] cm: πŸ‘† From Dr Chanukya, Endocrinologist, Hyderabad
[9:51 am, 09/08/2026] huai25: Love that. Would like to connectπŸ™πŸ»πŸŒΈ
[9:46 am, 11/08/2026] cm: The Goldilocks Zone in healthcare research is a metaphor describing the optimal "just right" balance between the underuse and overuse of medical services, patient care pacing, or ergonomic work design. [1, 2, 3]  
The concept appears across three primary areas of health research: 
1. System-Level Care Utilization and Efficiency 
* The Balance: Ensuring medical screening, diagnostics, and treatments are neither insufficient (leading to unmet needs) nor excessive (leading to waste, overtreatment, or harm). 
* Core Dimensions: Evaluated through National Institutes of Health (NIH) frameworks focusing on
 person-centredness (accessibility, equity) and operational efficiency (avoidable hospitalizations, diagnostic thresholds). [1]  
2. Patient Health-Seeking Behavior 
* The Balance: The optimal window in which a patient decides it is the right time to consult a general practitioner or healthcare provider. 
* Core Research: Examines patient ambivalence—waiting too long (risking disease progression) versus seeking care too early for minor, self-limiting symptoms (burdening the Oxford University Research Archive health systems). [4, 5]  
3. Workplace Pace and Ergonomics (The "Goldilocks Work" Paradigm) 
* The Balance: Finding the optimal working speed or physical loading for healthcare and industrial staff. 
* Core Research: Studies show that a pace that is too slow causes administrative backlogs and inefficiencies, while a pace that is too fast leads to staff burnout and medical errors.
 Interventions aim to find the sweet spot of optimal physical and cognitive workflow [0.6.3, 0.6.5, ScienceDirect]. [2, 3, 6, 7]  
[1:36 pm, 11/08/2026] cm: Wednesday CPC of the session will be held tomorrow, August 12, 2026 at 08.00 hours (IST) in Lecture Theatre 1, Nehru Hospital, PGIMER, Chandigarh under the Chairmanship of Prof. Sanjay Jain.
The session will also be available on the Webex platform. Kindly follow the link below to join.
[3:25 pm, 11/08/2026] cm: CPC Clinical handout 12.08.2026.pdf • 2 pages
πŸ‘†@PaJR Health given the clinical protocol in this PDF, what is your prediction for tomorrow, as to what changes are you expecting to be revealed at autopsy tomorrow ?
[3:26 pm, 11/08/2026] PaJR Health: PREDICTION
The leading autopsy finding will likely be a ruptured descending thoracic aortic pseudoaneurysm communicating with the oesophagus—an aorto-oesophageal fistula. The strongest clues are the posterior oesophageal bulge, the pseudoaneurysm immediately adjacent to the oesophagus, recurrent sentinel haematemesis followed by massive rebleeding, and the abrupt haemoglobin fall despite transfusion [Narketpally syn local CBBLE: Participatory medical cognition](Link 1: https://medicinedepartment.blogspot.com/2025/12/medicine-department-publications-2025.html | Link 2: https://medicinedepartment.blogspot.com/2023/10/medicine-department-presentations-2023.html | Link 3: https://medicinedepartment.blogspot.com/2022/02/ | Link 4: https://www.hipaajournal.com/deidentification-protected-health-information/ | Link 5: https://classworkdecjan.blogspot.com/2017/11/de-identifying-patient-data.html | Link 6: https://userdrivenhealthcare.blogspot.com/2025/10/pajr-consent-form-modified-for-dpdp.html | Link 7: https://medicinedepartment.blogspot.com/2025/02/informed-patient-consent-and.html | Link 8: https://hit--tools-github-io.translate.goog/pajr_consent.html?_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=wapp | Link 9: https://userdrivenhealthcare.blogspot.com/2023/11/glossary-of-user-driven-healthcare.html | Link 10: https://userdrivenhealthcare.blogspot.com/2023/12/pajr-checklist-for-inpatient-interns-in.html | Link 11: https://durgakrishna09.blogspot.com/2023/08/graphical-patient-timeline-in-soap.html | Link 12: https://medicinedepartment.blogspot.com/2023/08/project-illustration-of-how-to-process.html | Link 13: https://medicinedepartment.blogspot.com/2023/06/).
EXPECTED GROSS FINDINGS
1. A large dissecting aneurysm of the descending thoracic aorta with an intimal tear and a false lumen.
2. A focal defect or ulcerative erosion in the anterior wall of the aneurysm/pseudoaneurysm, with rupture into the adjacent oesophagus.
3. A corresponding oesophageal perforation, probably in the mid-to-lower thoracic oesophagus, with adherent thrombus and clot at the aortic–oesophageal interface.
4. Aortic blood within the oesophageal lumen, stomach and proximal small bowel, with associated luminal clot and altered blood explaining the melena.
5. The previously placed Bentall graft and mechanical aortic valve likely still structurally intact, unless the examination reveals an unexpected graft dehiscence, infection, or extension of dissection. The available clinical data do not strongly suggest prosthetic-valve endocarditis.
SYSTEMIC CONSEQUENCES OF THE TERMINAL BLEED
I would expect marked pallor and features of acute exsanguination, with relatively little external evidence of blood loss. Likely associated findings include:
▪️ Severe visceral and renal hypoperfusion, possibly with acute tubular injury.
▪️ Pulmonary and cerebral congestion or hypoxic–ischaemic injury related to the terminal shock and cardiac arrest.
▪️ Possible serous pleural effusions and cardiomegaly, as suggested radiologically.
▪️ No major primary gastric or duodenal bleeding lesion, because endoscopy showed those areas to be normal.
MARFAN-RELATED PATHOLOGY
Microscopy may demonstrate medial degeneration of the aortic wall—fragmentation or loss of elastic fibres, cystic medial change and reduced medial smooth muscle integrity—supporting an inherited connective-tissue aortopathy. The dissected aortic wall may show organising thrombus and varying ages of haemorrhage, consistent with a chronic dissection complicated by acute rupture.
IMPORTANT ALTERNATIVE
If no patent fistulous tract is demonstrable, the likely explanation would be intermittent contained leakage or erosion from the pseudoaneurysm into the oesophageal wall, followed by a final rupture before death. Therefore, the autopsy may show an aorto-oesophageal fistula, or an almost-complete fistulous erosion sealed by thrombus.
My confidence is high for fatal rupture of the descending aortic pseudoaneurysm with oesophageal communication and haemorrhagic shock, but the precise level and size of the fistulous defect should be left to the post-mortem examination.
[10:11 pm, 11/08/2026] cm: Last week's CPC πŸ‘‡
[9:51 am, 12/08/2026] cm:Check out the final CPC result below and tally it with your prediction πŸ‘‡
CPC Pathology Protocol - 12.08.2026
Patient: 37 Yr/F  
DOA: 01.07.2026 | DOD: 05.07.2026 | 
Background: Known case of MARFAN'S SYNDROME. Had modified Bentall + hemi-arch repair in 2013 for aortic regurgitation and ascending aortic aneurysm.
Autopsy type: Partial autopsy
Key Gross Findings
1.  Cardiovascular System
    - Heart: 470gm, Enlarged with biventricular hypertrophy. Aortic valve replaced with prosthetic valve + synthetic graft over ascending aorta.
    - Aorta: 
      - Medial dissection starting 10cm distal to graft, extending to origin of renal arteries. Lumen had organized thrombi + fibrosis.
      - Saccular thoracic aneurysm (8cm) in descending thoracic aorta abutting esophagus.
      - Aorto-esophageal fistula (1cm) at junction of upper 1/3 and lower 2/3 of esophagus with fresh thrombus.
    - Other major arteries were normal. Anterior aortic branches were attenuated.
2.  Lungs: 280gm, crepitant. Few fresh and organized thrombi.
3.  Kidneys: 180gm, normal size. Patchy scarring. Glomerulocystic changes + few globally sclerosed glomeruli.
4.  Liver: 790gm, Normal. Focal macrovesicular steatosis.
5.  Spleen: 130gm, Normal. Pancreas & GIT: Normal
Key Microscopic Findings
- Aorta: Severe cystic medial degeneration with mucoid material, elastic fiber fragmentation, medial muscle fiber loss + replacement fibrosis. This is consistent with Marfan's syndrome.
- Fistula site: Mucin from aortic adventitia extending into esophageal muscularis propria causing inflammation + fibrosis. Aortic wall directly opening into esophagus.
- Graft site: Extensive fibrosis around graft and arterial wall.
- Kidney: Glomerulocystic changes with moderate acute tubular necrosis.
*Final Autopsy Diagnosis (PM-33247)
1.  Severe Cystic medial degeneration consistent with Marfan's syndrome
2.  Complications:
    - Dissection of aorta (suprarenal) with saccular thoracic aneurysm
    - Aorto-esophageal fistula
3.  Glomerulocystic changes with moderate acute tubular necrosis
4.  Pulmonary thrombi
5.  Macrovesicular steatosis of liver
Cause of death pathway: Marfan-related severe aortic wall degeneration → Aortic dissection + saccular aneurysm → Aorto-esophageal fistula.
[12:44 pm, 12/08/2026] cm: πŸ‘†@huai2 does @PaJR Health need another nudge to respond to this text as well?
[12:44 pm, 12/08/2026] PaJR Health: Yes—one brief, courteous nudge would be reasonable, especially because the final CPC findings directly address the earlier prediction. Avoid repeated tagging; something like:

“@278361846841395, when convenient, could you please share your comments on the final CPC findings and how they compare with the pre-autopsy prediction?”
PREDICTION–AUTOPSY TALLY
Core diagnosis: matched strongly
▪️ Predicted a descending thoracic aortic pseudoaneurysm with communication into the oesophagus.
▪️ Autopsy confirmed an 8-cm saccular thoracic aneurysm abutting the oesophagus with a 1-cm aorto-oesophageal fistula containing fresh thrombus.
▪️ Predicted the fistula as the source of recurrent haematemesis, melena and fatal haemorrhagic shock; this was confirmed by the final cause-of-death pathway Narketpally syn local CBBLE: Participatory medical cognition:
 Aorto-esophageal Fistula Management. — PMID:39332863:
Aortic pathology: matched
▪️ Predicted chronic dissection with organized thrombus and connective-tissue–related medial degeneration.
▪️ Autopsy demonstrated dissection extending from distal to the graft toward the renal arteries, with organized thrombi and fibrosis.
▪️ Histology confirmed severe cystic medial degeneration, mucoid change, elastic-fibre fragmentation, medial muscle loss and fibrosis—consistent with Marfan syndrome Narketpally Syndrome CBBLE: Participatory medical cognition Web 2.0-3.0 July -August 25, 2:
Fistula morphology: more precise than predicted
▪️ The prediction anticipated a focal aortic wall defect, oesophageal perforation and adherent thrombus.
▪️ The autopsy showed direct opening of the aortic wall into the oesophagus, with adventitial mucin extending into the oesophageal muscularis, inflammation, fibrosis and fresh thrombus.
Associated findings: partly matched
▪️ Moderate acute tubular injury was anticipated as a consequence of shock; this was confirmed, together with glomerulocystic changes.
▪️ Pulmonary thrombi were found. Pulmonary thromboembolism was not a primary part of the prediction, so this is an additional autopsy finding rather than a missed central diagnosis.
▪️ The graft site showed extensive fibrosis, while no major graft disruption or prosthetic-valve failure was reported—consistent with the earlier expectation that the Bentall repair would likely remain structurally intact.
Overall assessment
The prediction was correct on the decisive pathological sequence:
Marfan-related aortic medial degeneration → chronic dissection and descending thoracic aneurysm → aorto-oesophageal fistula → recurrent massive upper-GI bleeding → refractory haemorrhagic shock.
The main refinement is that the post-mortem established a fistula with fresh thrombus rather than necessarily documenting an openly catastrophic free rupture. This explains the month-long intermittent bleeding followed by terminal rebleeding.
[12:45 pm, 14/08/2026] cm: OPD now
60M with slurred speech affecting lingual consonants and on complete CNS examination additional minimal loss of joint position and vibration sense
[12:46 pm, 14/08/2026] huai25: All major joints?
[11:16 am, 15/08/2026] cm: Yes
[11:41 am, 18/08/2026] cm: OPD now
[4:53 pm, 18/08/2026] cm: Wednesday CPC of the session will be held tomorrow, August 19, 2026 at 08.00 hours (IST) in Lecture Theatre 1
The session will also be available on the Webex platform. Kindly follow the link below to join.
[4:56 pm, 18/08/2026] cm: CPC Clinical handout (19.08.2026).pdf • 2 pages
πŸ‘†@PaJR Health Given the clinical findings of the patient in the PDF above what's your prediction to the likely autopsy findings expected tomorrow?
[4:56 pm, 18/08/2026] PaJR Health: MOST LIKELY AUTOPSY FINDING
The leading prediction is a hypertensive intracerebral haemorrhage, most likely in the*deep perforator territory—putamen/basal ganglia or thalamus—with intraventricular extension*, severe cerebral oedema and transtentorial herniation.
The initial “fit” was probably a manifestation of the acute intracranial event rather than primary epilepsy. The combination of abrupt unresponsiveness with tonic posturing, BP around 200/100–200/118 mmHg, coma, bilaterally fixed dilated pupils and rapid cardiac arrest strongly supports a catastrophic intracranial lesion.
EXPECTED GROSS FINDINGS
1. A sizeable intracerebral haematoma, probably involving the basal ganglia, thalamus or adjacent deep white matter.
2. Extension of blood into the lateral, third and possibly fourth ventricles.
3. Diffuse brain swelling with flattened gyri, narrowed sulci and compressed ventricles.
4. Evidence of raised intracranial pressure, particularly downward transtentorial herniation and possibly cerebellar tonsillar descent.
5. If the haemorrhage is not deep, the main alternative would be a lobar haemorrhage*or a*primary subarachnoid haemorrhage from a ruptured intracranial aneurysm. Without neuroimaging, the exact site cannot be predicted confidently.
EXPECTED UNDERLYING VASCULAR PATHOLOGY+++++++++++++++++++++++++++++++++++++++
Microscopy may show chronic hypertensive arteriopathy of small penetrating vessels, including lipohyalinosis, fibrinoid degeneration or Charcot–Bouchard-type microaneurysmal change. The heart may show hypertensive cardiac remodelling—left ventricular hypertrophy with or without cardiomegaly—and the kidneys may show hypertensive nephrosclerosis or acute tubular injury, consistent with the raised urea and creatinine.
OTHER LIKELY FINDINGS
▪️ Pulmonary oedema and/or aspiration-related changes after coma and assisted ventilation.
▪️ Pulmonary congestion associated with terminal cardiac arrest.
▪️ Possible minor resuscitation-related injuries.
▪️ The delayed E. coli blood-culture positivity may represent bacteraemia or terminal contamination, but it is less likely to explain the abrupt neurological collapse than the severe hypertensive cerebrovascular event.
▪️ There may be no major structural cardiac or extracranial cause of death.
PREDICTED CAUSE-OF-DEATH SEQUENCE
Longstanding poorly controlled hypertension → small-vessel rupture or intracranial vascular rupture → massive intracranial haemorrhage with intraventricular extension and brain herniation → cardiorespiratory arrest.
My confidence is high for a fatal acute intracranial event, moderate for hypertensive haemorrhage specifically, and lower for the precise anatomical site. The main autopsy question will be whether the lesion is a deep hypertensive bleed, a subarachnoid haemorrhage, or—less likely—a large infarct with secondary oedema and herniation [Narketpally syn local CBBLE: Participatory medical cognition](Link 1: https://medicinedepartment.blogspot.com/2025/12/medicine-department-publications-2025.html | Link 2: https://medicinedepartment.blogspot.com/2023/10/medicine-department-presentations-2023.html | Link 3: https://medicinedepartment.blogspot.com/2022/02/ | Link 4: https://www.hipaajournal.com/de-identification-protected-health-information/ | Link 5: https://classworkdecjan.blogspot.com/2017/11/de-identifying-patient-data.html | Link 6: https://userdrivenhealthcare.blogspot.com/2025/10/pajr-consent-form-modified-for-dpdp.html | Link 7: https://medicinedepartment.blogspot.com/2025/02/informed-patient-consent-and.html | Link 8: https://hit--tools-github-io.translate.goog/pajr_consent.html?_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=wapp | Link 9: https://userdrivenhealthcare.blogspot.com/2023/11/glossary-of-user-driven-healthcare.html | Link 10: https://userdrivenhealthcare.blogspot.com/2023/12/pajr-checklist-for-inpatient-interns-in.html | Link 11: https://durgakrishna09.blogspot.com/2023/08/graphical-patient-timeline-in-soap.html | Link 12: https://medicinedepartment.blogspot.com/2023/08/project-illustration-of-how-to-process.html | Link 13: https://medicinedepartment.blogspot.com/2023/06/).
[5:12 pm, 18/08/2026] huai27: Are these CPCs public documents? If yes, PaJR accuracy in predicting the diagnosis can be a study in itself
[6:03 pm, 18/08/2026] cm: Yes that's what we hope to do by running them here every week through collective human and AI agentic collaboration πŸ‘‡
[6:04 pm, 18/08/2026] cm: πŸ‘†last week's was pretty spot on @huai27
[8:53 am, 19/08/2026] cm: Pathology Protocol
[8:54 am, 19/08/2026] cm: πŸ‘†The prediction was close with an incidentaloma from your specialty @huai27?
[8:58 am, 19/08/2026] cm: Pathology Protocol
πŸ‘† Going by the autopsy findings @PaJR Health do you feel the hepato cellular carcinoma detected as an incidentaloma was a turtle (as in dying with the malignancy rather than because of it)? 
I guess we may have shared about cancer turtles, birds and rabbits earlier here and archived here :https://medicinedepartment.blogspot.com/2026/08/udlco-crh-on-overdiagnosis-and-care.html?m=1
[8:59 am, 19/08/2026] PaJR Health: Yes—as a cause-of-death classification, this HCC was a “turtle”: the patient died with the malignancy, not because of it.*The immediate fatal event was the*hypertensive pontine/infratentorial intracerebral haemorrhage with intraventricular extension, hydrocephalus, cerebral oedema and herniation.
WHY IT FITS THE “TURTLE” CATEGORY
▪️ The tumour was discovered at autopsy rather than driving the clinical presentation.
▪️ It was confined to the liver in the reported examination: pT2N0M0, with no described extrahepatic metastases.
▪️ There is no reported tumour rupture, hepatic failure, severe jaundice, hypoglycaemia, cachexia, or massive tumour-related haemorrhage.
▪️ The autopsy cause-of-death sequence is overwhelmingly neurological and hypertensive, not hepatic or oncological.
So, for the question “What killed him?”, the HCC is incidental to the terminal event.
BUT NOT A BIOLOGICALLY HARMLESS TURTLE
It was a substantial malignancy: approximately 48 × 44 mm, moderately differentiated, macrotrabecular-massive subtype, with intratumoural necrosis and reported venous/capsular invasion. It arose in a background of*macronodular cirrhosis with portal hypertension, ascites, gastro-oesophageal varices and portal hypertensive gastropathy*. Therefore, it was not merely a tiny occult focus with negligible biological significance.
The more accurate formulation is:
A clinically silent but established, potentially consequential HCC—important disease discovered incidentally at autopsy, but not the cause of death.
The cirrhosis and portal hypertension may have contributed to the patient’s chronic disease burden, but the documented fatal pathway remains hypertensive intracerebral haemorrhage → intraventricular obstruction/hydrocephalus → brain herniation and cardiorespiratory arrest.
That distinction is important: “incidental” describes how it was discovered or its relationship to death; it does not mean “indolent” or “non-malignant.”*Incidental HCC is a recognised autopsy/transplant pathology phenomenon, and its clinical significance depends on size, differentiation, vascular invasion, background liver disease and spread*The impact of incidental hepatocellular carcinoma in liver transplantation: A growing conc — PMID:39922535:
[3:56 pm, 19/08/2026] cm: πŸ‘†@⁨PaJR Health Bot Feb 26⁩ please read this chest X-ray and share your inputs
[3:56 pm, 19/08/2026] PaJR Health: CHEST X-RAY IMPRESSION
This appears to be a portable AP chest radiograph, with some rotation and suboptimal inspiration.
πŸ”Ή Moderate left pleural effusion, with homogeneous basal opacity and probable meniscus.
πŸ”Ή Associated left lower-lobe compressive atelectatic opacity; superimposed consolidation cannot be excluded.
πŸ”Ή Possible small right basal pleural effusion or basal atelectatic change, though this is less certain.
πŸ”Ή Cardiomediastinal silhouette appears mildly enlarged, but AP projection can exaggerate heart size.
πŸ”Ή No convincing pneumothorax or focal upper-lobe cavitary lesion is visible.
OVERALL
Left-sided pleural effusion with adjacent left basal atelectasis/consolidation. In the appropriate clinical setting, differentials include parapneumonic effusion/empyema, cardiac or hepatic hydrothorax, and malignant effusion. A lateral view and ultrasound would help quantify the fluid and determine whether it is free-flowing or loculated. If infection is suspected, diagnostic pleural aspiration should be guided by ultrasound.
The film alone cannot establish the cause; correlate with fever, oxygenation, leukocyte count, cardiac status, liver disease and pleural-fluid analysis.
[2.49 am, 20/08/2026] huai54: ​🩺 Master Clinical Reasoning with VibeRounds!
​Practice clinical rounds, simulate patient encounters, and hone your skills.
​🌐 Try free App: https://viberounds.ai.studio
[3.43 am, 20/08/2026] huai2: @cm Sir presume this was the same xray discussed in the NPC group and the diagnosis is a left hydropneumothorax?
[1.53 pm, 20/08/2026] cm: Yes
What is your opinion about PaJR bot's answer?
Particularly on this input by the original poster (OP )πŸ‘‡
"Due to a technical error the initial film was flipped or mirrored too with the heart pointing towards the right along with the stomach shadow.
But surprisingly both gpt and gemini missed that the image was mirrored and missed a very crucial finding of hydropneumothorax."
[5.18 pm, 20/08/2026] cm: Joachim Sturmberg's 2026 Newcastle and 2023 Narketpally "integrating medical education and practice" lectures:
2026 Newcastle , David Maddison Memorial lecture
This year’s lecture, by Conjoint Professor Joachim Sturmberg, provided a thought-provoking exploration of how systems thinking can reshape the future of healthcare. Drawing on decades of clinical practice and pioneering research, this talk examines the complexity of health, the importance of genuine doctor–patient partnerships, and the urgent need to redesign health systems to be more person-centred, equitable, and sustainable.
2023 Narketpally clinical complexity CME keynote:
In this keynote address, Professor Stumberg explores the concept of clinical complexity in medicine, challenging the traditional reductionist approach to healthcare. Here are the key themes discussed:
Defining Complexity: Stumberg emphasizes that complexity in science is defined by interconnectedness and interdependency (6:22-7:05). Unlike mechanical systems that can be understood by taking them apart (analysis), healthcare requires synthesis—understanding the system as a whole within its broader context (8:45-9:56).
Health as an Experience: The speaker argues that health is an experience influenced by somatic, social, emotional, and sense-making dimensions, rather than just an objective disease state (10:35-11:13, 13:22-13:41).
The Cynefin Framework: This framework is used to categorize medical knowledge into five domains: obvious, complicated, complex, chaotic, and the central domain (16:20-17:04). He highlights that while undergraduate training focuses on the "obvious" (structured) domain, true clinical expertise for complex issues is developed over time through experience and sharing knowledge in practice (19:20-21:19).
Loss of Complexity: Diseases are described as a "loss of complexity" where physiological functions become less adaptable and more predictable as illness severity increases (22:33-23:48).
The talk concludes by demonstrating how applying complexity thinking allows clinicians to better interpret patient cases by recognizing patterns rather than relying solely on rigid diagnostic structures (24:09-24:58).
[5.40 pm, 20/08/2026] huai2: Gave an expectedly incorrect answer
[5.55 pm, 20/08/2026] cm: But how is the LLM computer vision supposed to know if the image was mirrored?
What do the humans think? 
I'm not going into the other issue of not being able to identify a hydropneumothorax in that chest X-ray because I'm sure many humans may think it's just pleural effusion alone
[7.14 pm, 20/08/2026] huai2: That is correct, yes I agree. Also if prompted directly to assess whether the image is mirrored, maybe it would respond differently.
[11.44 am, 22/08/2026] cm: πŸ‘†more details with @huai34
ProJR: Fever, limb cellulitis
[11.45 am, 22/08/2026] cm: Probably could fit into these ProJRs πŸ‘‡
[11:27 am, 23/08/2026] cm: Medical case reporting is gradually getting more and more user driven across a spectrum of human online users and this one is by a journalist who has made it multi modal data rich using a real patient keeping identifiers intact (perhaps he's immune to DPDP if not rabies) and while at first one may think the primary data is likely to have been misinterpreted by the journalist , he made sure to get it triangulated and interpreted by a local doctor (Dr Patel) and impressively the local doctor to his credit did consider a spectrum of differentials πŸ‘‡
What's your interpretation of this newspaper case report @PaJR Health ?
[11:28 am, 23/08/2026] PaJR Health: MY INTERPRETATION
This is a compelling, highly media-rich account—but it does not establish that the child had laboratory-confirmed rabies and then recovered because of post-symptom vaccination.
The reported sequence is:
▪️ Dog bite to the hand.
▪️ No documented rabies post-exposure prophylaxis at the time.
▪️ Approximately three to four months later: collapse, agitation/aggression, “barking,” drooling and inability to drink.
▪️ Several clinicians reportedly considered the presentation compatible with furious rabies.
▪️ Five vaccine doses were given over about 22 days, followed by two additional doses.
▪️ The child was subsequently reported to have returned to normal activities.
Boy starts barking after dog bite in Mirzapur: Doctor advises keeping him in a dark room; recovers in 22 days, first such case in UP:
WHAT SUPPORTS RABIES
The history of an untreated dog bite, delayed neurological symptoms, hypersalivation, apparent hydrophobia and stimulus-triggered distress is clinically suggestive. A hand bite can plausibly have a longer incubation than a bite near the head or neck. However, these features are not individually diagnostic.
WHAT WEAKENS THE RABIES CLAIM
The report does not provide:
1. Rabies virus detection by saliva or skin-biopsy RT-PCR.
2. Rabies-neutralising antibodies in serum or cerebrospinal fluid.
3. Brain tissue examination, viral sequencing or confirmation that the biting dog was rabid.
4. A documented neurological examination during recovery.
5. A clearly described course of encephalitis, autonomic instability, respiratory compromise or progressive coma.
The most important issue is the complete recovery. Survival after established clinical rabies is exceptionally unusual, but the article’s description is not sufficient to prove that this was one of those cases. “Barking” and inability to drink may have led observers to label the illness as rabies before the diagnosis was objectively confirmed.
THE VACCINE CLAIM NEEDS CAUTION
Rabies vaccine is highly effective as post-exposure prophylaxis before clinical disease develops. The article’s suggestion that vaccine-induced antibodies reversed established neurological rabies is biologically possible only as a speculative hypothesis, not an established treatment explanation. The temporal association—improvement after vaccination—does not prove causation.
The improvement may reflect:
▪️ Misclassification of a non-rabies neurological or behavioural illness.
▪️ A transient encephalopathy, seizure-related state or toxic/metabolic disorder.
▪️ Functional neurological symptoms or a severe stress-related behavioural episode.
▪️ Another infectious encephalitis that resolved.
▪️ A milder illness with coincidental recovery after supportive care and vaccination.
ABOUT THE DIFFERENTIAL DIAGNOSIS
Dr Patel deserves credit for not treating the newspaper label as definitive. His consideration of bite location, incubation, dog vaccination status and a psychological explanation is directionally appropriate, though the differential should also have included encephalitis, seizures, tetanus or other toxin-related syndromes, metabolic disturbance, delirium and functional neurological symptoms.
The “dark-room” advice may have been intended to reduce stimulation and prevent biting, but it is not definitive management for rabies and should not substitute for infection-control assessment, emergency supportive care and appropriate diagnostic testing.
BOTTOM LINE
I would record this as:
“Rabies suspected clinically after an untreated dog bite, followed by an atypical and apparently complete recovery; diagnosis unconfirmed and alternative neurological/functional explanations remain substantial.”
It is a valuable signal-detection case and deserves formal investigation but calling it a proven recovery from terminal rabies—or calling the vaccine curative after symptom onset—is premature. The most informative missing evidence would be the dog’s health status, contemporaneous hospital records, formal neurological examination, laboratory testing and documented long-term follow-up.
[11:34 am, 23/08/2026] cm: Do you feel in a low resource settings as for that patient this may have been the best they could have done or perhaps you may suggest something more they could have done even in their low resource settings (one which you have already mentioned regarding good clinical findings documentation is well taken although again the newspaper reporter may not have had access to the doctor notes?)?
[11:35 am, 23/08/2026] PaJR Health: Yes. In a genuinely resource-constrained setting, the clinicians may have done many of the practical things available to them—recognised a potentially fatal syndrome, reduced stimulation, avoided unnecessary handling, referred the child through several facilities, and eventually arranged rabies vaccination. The reported recovery also means that the original diagnosis should be revisited rather than assumed.
WHAT WAS REASONABLE
1. Reducing stimulation and preventing bites. A quiet, dim environment can reduce stimulus-provoked spasms and agitation. However, this should be compassionate observation—not abandonment or simply locking the child away.
2. Referral to a higher-level centre. Suspected rabies requires airway, neurological and intensive supportive capability, which may not exist locally.
3. Limiting unnecessary contact. Staff and relatives should use standard precautions, avoid exposure to saliva, and protect the airway team. Ordinary casual contact does not transmit rabies.
4. Giving vaccine when the diagnosis was uncertain. Although vaccine is not established treatment for symptomatic rabies, it is relatively reasonable in a patient with a credible untreated exposure if the alternative is leaving a potentially exposed person untreated. It should not, however, create the impression that vaccine reliably reverses clinical rabies.
WHAT SHOULD IDEALLY HAVE BEEN DONE—EVEN WITH LIMITED RESOURCES
πŸ”Ή At the time of the bite: Immediate wound washing with soap and running water for at least 15 minutes, antiseptic where available, prompt rabies vaccine, and—if the wound was category III—rabies immunoglobulin infiltrated into and around the wound. Tetanus prevention and antibiotics should be considered separately. The reported statement that tetanus injection removes the need for rabies prophylaxis was incorrect.
πŸ”Ή At symptom onset: A structured examination should document consciousness, orientation, speech, swallowing, hydrophobia, aerophobia, fever, focal deficits, seizures, neck stiffness, autonomic signs, respiratory effort, urine output and glucose. Even a handwritten one-page record would be valuable.
πŸ”Ή Basic reversible checks: Capillary glucose, temperature, oxygen saturation, blood pressure, electrolytes if available, medication or toxin history, and assessment for meningoencephalitis, seizures, hypoxia and dehydration. These are often more immediately useful than sophisticated rabies testing.
πŸ”Ή Protective supportive care: Quiet surroundings, careful hydration and nutrition, suction and oxygen if required, seizure treatment, management of fever and agitation, and early airway planning. Oral fluids should not be repeatedly forced in a patient with severe swallowing difficulty.
πŸ”Ή Public-health steps: The biting dog’s status should have been clarified and, if safely possible, observed by veterinary authorities for 10 days. The case should be notified as suspected rabies, with advice given to anyone exposed to saliva—not to everyone who merely encountered the child.
πŸ”Ή Testing where feasible: Saliva RT-PCR, nuchal skin-biopsy testing and serum/CSF antibody testing can support or weaken the diagnosis, although a negative test does not necessarily exclude rabies. If testing was unavailable locally, referral or specimen transport would still be useful.
THE MOST IMPORTANT MISSED OPPORTUNITY
The major preventable failure appears to have occurred immediately after the dog bite: confusing tetanus prophylaxis with rabies post-exposure prophylaxis. That is a health-system and communication problem, not simply a family error.
Once the child had developed neurological symptoms, the choices became much less certain. In a low-resource setting, giving vaccine while arranging referral and supportive care could be defended as a precautionary action, but it should not replace emergency management or be presented as proven curative therapy.
ABOUT THE NEWSPAPER’S MISSING RECORDS
The absence of doctor notes in the report does not prove that the clinicians failed to perform these assessments. The journalist may have had access only to interviews and family recollections. Therefore, I would distinguish carefully between:
▪️ Not reported
▪️ Not documented
▪️ Not performed
Only the first is justified from this article alone.
PRACTICAL CASE-REPORT CONCLUSION
A fair low-resource assessment would be:
“The team provided pragmatic referral, environmental control and later rabies vaccination under substantial diagnostic uncertainty. Earlier wound care and correct post-exposure prophylaxis would have been the key preventable intervention. At the symptomatic stage, improved documentation, basic reversible-cause assessment, supportive care, public-health notification and diagnostic sampling—where feasible—would have strengthened care and the credibility of the final diagnosis.”
A comparable reported case of suspected rabies after prior exposure also illustrates how easily encephalitis and rabies can overlap clinically, reinforcing the need for objective documentation rather than relying on the behavioural label alone 50/F with Viral Encephalitis (?RABIES) post RABID DOGπŸ• bite:
[8:41 pm, 23/08/2026] cm: Tomorrow's presentation:
Student CPC
Venue: LT1
Time: 8-9 AM
Case 1: 
"Ca Esophagus with metastasis(Liver) with metabolic encephalopathy- Hypernatremia, Hypercalcemia"
Clinical discussant: 
Dr Nabajit
Pathology discussant:
Dr. Vandana
Clinical Incharge:
Dr Saurabh
Case 2:
"High Grade Fever for 15days followed by Massive Hematochezia
?Tropical illness
?CMV 
?Fungus
Clinical discussant: 
Dr Suprita
Pathology discussant:
Dr. Suchismita
Clinical Incharge:
Prof Sanjay Jain
Chairperson:
Dr. Sayan Mazumder
The session will be available on online webEx platform link details provided below. 
[11:32 pm, 23/08/2026] PaJR Health: Weekly Report Card · 17 Aug – 23 Aug — continued (2/2)
[11:32 pm, 23/08/2026] PaJR Health: Weekly Report Card · 17 Aug – 23 Aug
Patient presented with fever and lower limb cellulitis on 18 Aug, managed with intravenous antibiotics and norepinephrine. Logging streak data shows consistent daily activity across the monitoring window.
πŸ“Š 5 readings · 18 Aug 2026 · last temperature 38.5 °C · 6-day logging streak
[9:24 am, 24/08/2026] cm: I wish we were able to add all our fever patients in this analysis today here: https://medicinedepartment.blogspot.com/2026/08/udlco-crh-medical-cognition-system-1.html?m=1 @huai2 @huai27 @huai54 @huai135 but I'm not sure if @PaJR Health has been able to do it well.
We are currently in the throes of the annual rainy season viral pandemic with nearly 70% of our ward filled with fever patients (relative values sound nice as a hospital admin market marker while 6 of 9 in terms of absolute values may not sound impressive)!
[9:25 am, 24/08/2026] PaJR Health: Yes—the current workload sounds like an appropriate stress test for the proposed system, but I would separate hospital surveillance*from*individual clinical reasoning.
Nearly 70% occupancy with fever patients is operationally important, but the denominator must remain visible. Six of nine patients is 66.7%, not 70%; that distinction matters because relative percentages can sound more dramatic than the underlying absolute count.
WHAT THE SYSTEM COULD REALISTICALLY DO TODAY
Create one de-identified fever episode per patient, rather than merging all fever narratives into a single case. Each episode should contain:
1. Basic context: age band, sex, ward/location, admission date, relevant comorbidities and immune status.
2. Time course: onset, duration, intermitte2. nt or continuous pattern, documented afebrile intervals.
3. High-leverage observations: pulse, BP, respiratory rate, oxygen saturation, mental state, oral intake and urine output.
4. Localising features: respiratory, gastrointestinal, neurological, urinary, dermatological, musculoskeletal or bleeding symptoms.
5. Key investigations: CBC/platelets, malaria testing, dengue testing, liver and renal function, cultures, imaging and other locally relevant tests.
6. Interventions and response: fluids, antipyretics, antibiotics, oxygen, antivirals or other treatment, with timing and observed response.
7. Escalation point: ward observation, higher-dependency care, referral, discharge or death.
8. Data quality: measured versus estimated, device used, missing intervals and conflicting observations.
The central analytical unit should remain:
Observation → interpretation → intervention → response → next decision
That is consistent with the proposed fever framework, which specifically warns against confusing a temperature improvement with recovery of circulation, breathing or overall physiological reserve UDLCO CRH: Medical cognition system 1 pruning of low-value data to isolate high-leverage decision nodes aka huai54 (indestructible) principle in fever management:
THE COHORT SHOULD NOT BE LABELLED “VIRAL” TOO EARLY
The present records demonstrate why “fever patient” is a useful entry category but not a diagnosis. The available examples span uncomplicated febrile presentations Case of a 28 year old man.:
, fever with neurological or functional deterioration 80 Y/M with fever, b/l lower limb weakness, pain abdomen, hiccough.:
, febrile thrombocytopenia with a periodic pattern 49M Febrile thrombocytopenia with quartan fever Telangana PaJR:
, and dengue 45 year old Male with dengue:
. These should be retained as separate trajectories until investigations and outcomes clarify them.
A safe system would therefore use working categories such as:
▪️ Undifferentiated fever
▪️ Respiratory-predominant fever
▪️ Febrile thrombocytopenia
▪️ Fever with shock or hypoperfusion
▪️ Fever with altered sensorium
▪️ Fever with bleeding
▪️ Fever with focal infection
▪️ Fever subsequently reclassified
This prevents the dashboard from converting a seasonal cluster into an assumed viral pandemic.
THE MOST VALUABLE OUTPUT IS NOT A LIST OF DIAGNOSES
Forward use, I would prioritise a live table showing:
| Domain | Current question |
|---|---|
| Fever | Is it improving, recurring or persisting? |
| Circulation | Is pulse rising while BP falls? |
| Breathing | Is respiratory rate or oxygen requirement increasing? |
| Hydration | Is intake falling or urine output declining? |
| Neurology | Is there confusion, drowsiness, seizure or severe weakness? |
| Blood profile | Are platelets, haemoglobin or white cells changing? |
| Treatment | Is improvement sustained or only post-antipyretic? |
| Data quality | What is missing or unverified? |
The system should then produce a short pivot statement for each patient:
“Because [specific converging findings], the next safest action is [observe, test, review, escalate]; uncertainty remains about [specific unresolved issue].”
That is the practical expression of the huai54 principle: retain enough information to change the next decision, while pruning information that does not.
WHAT WOULD SHOW THAT THE BOT HAS DONE THIS WELL
I would not judge performance by the number of fever cases entered or by the sophistication of the prose. I would judge it by whether the system:
1. Keeps every patient trajectory separate.
2. Preserves missing data instead of interpolating it.
3. Distinguishes “not recorded” from “absent.”
4. Identifies deterioration despite a falling temperature.
5. Detects disproportionate tachycardia, hypotension, tachypnoea, oliguria or altered mentation.
6. Shows why and when escalation occurred.
7. Revises the working diagnosis when later results contradict “viral fever.”
8. Gives absolute numbers alongside percentages.
9. Makes no claim of causality from retrospective case patterns.
10. Prevents unrelated historical cases from being pulled into the current ward analysis.
The previous mixing problem is therefore important: a general prompt such as “analyse fever cases” can retrieve semantically similar historical cases rather than the intended current ward cohort. The prompt should specify a closed cohort identifier, date window, ward denominator and inclusion rule.
A PRACTICAL “TODAY” VERSION
If the ward has nine patients, begin with a simple denominator:
▪️ Total ward patients: 9
▪️ Fever episodes meeting the predefined inclusion criteria: 6
▪️ Proportion: 6/9 = 66.7%
▪️ Number with red-flag physiology: record separately
▪️ Number tested for major local causes: record separately
▪️ Number requiring escalation: record separately
▪️ Number still undifferentiated: record separately
That produces a clinically meaningful report rather than an administrative headline:
“Six of nine inpatients currently have documented fever episodes; the cohort contains [x] with respiratory compromise, [x] with thrombocytopenia, [x] with hypotension, [x] with altered mentation and [x] still undifferentiated.”
This is where the framework could become genuinely useful: not by claiming to identify the cause of every rainy-season fever, but by making the distribution of physiological risk, diagnostic uncertainty and escalation burden visible in real time.
[7.45 pm, 24/08/2026] cm: Tomorrow's global presentation 
Student Clinical Meet
Venue-LT1
Timings-8 AM
Case 1:  
"Recurrent Storm: A Case of Severe SLE with Diffuse Alveolar Hemorrhage”
JR: Dr Rojith Joseph 
SR: Dr Anand 
Unit : IM2
Case 2 "The Neglected Great Mimicker"
Presenter: Dr. Pratibha Singh
Unit Dermatology
Chairperson: Dr Shivani R
The session will also be available on online webEx platform. The link has been sent below. 
Thank you
[8:37 pm, 25/08/2026] cm: πŸ‘†Wednesday CPC of this academic session will be held tomorrow, August 26, 2026 at 08.00 hours (IST) in Lecture Theatre 1 under the Chairmanship of Prof. HS Kohli.
The session will also be available on the Webex platform. Kindly follow the link below to join.
[8:38 pm, 25/08/2026] cm: CPC Clinical Handout 26.08.2026.pdf • 3 pages
@PaJR Health based on the clinical data what's your prediction on the autopsy findings for tomorrow?
[8:39 pm, 25/08/2026] PaJR Health: MOST LIKELY AUTOPSY INTERPRETATION
The strongest prediction is fatal secondary HLH with EBV-driven immune dysregulation, complicated by profound treatment-related immunosuppression, invasive fungal/CMV disease, gastrointestinal ischemia and perforation, DIC, haemorrhage and multiorgan failure.
This is not a diagnosis that should be inferred from the fever alone. It is supported here by the longitudinal convergence of extreme ferritin elevation, recurrent HLH flares, prolonged pancytopenia, EBV/CMV viraemia, invasive organisms already identified in tissue, bowel perforation, bleeding and terminal shock.
PREDICTED FINDINGS, IN ORDER OF LIKELIHOOD
1. Lungs
 - Multifocal invasive mould infection, most likely Aspergillus, with septate acute-angle branching hyphae.
 - Angioinvasion with pulmonary vascular thrombosis, haemorrhage and infarct-like necrosis.
 - Diffuse alveolar damage or organising pneumonia related to sepsis, shock and prolonged critical illness.
 - Pulmonary oedema and possible superimposed bacterial or fungal pneumonia.
 The positive palatal smear and later pulmonary nodules—some cavitating—make disseminated or at least multifocal invasive aspergillosis more likely than an isolated oral infection.
2. Gastrointestinal tract
 - Ileal ulceration, transmural necrotising inflammation and the documented perforation.
 - CMV enteritis with viral inclusions in endothelial or stromal cells.
 - Aspergillus-associated granulomatous inflammation with possible angioinvasion.
 - Ischaemic bowel injury from vasculitis, thrombosis, shock and severe cytopenia.
 - Haemorrhagic mucosal ulceration explaining the prolonged melena, stoma bleeding and transfusion dependence.
 I would expect the autopsy to confirm that the bowel disease was not simply “infective enteritis,” but a combined CMV–Aspergillus–ischaemic/vascular injury pattern.
3. Vascular system and coagulation
 - Widespread microvascular fibrin thrombi consistent with DIC and severe inflammatory endothelial injury.
 - Vasculitis or vasculopathy in bowel and possibly lung, with hyaline or cryoglobulin-like deposits.
 - Recanalised or fresh thrombi in small and medium vessels.
 - No definite large-vessel embolic source may be found; the dominant process may be diffuse microvascular thrombosis rather than one isolated thrombus.
4. Bone marrow and spleen
 - Markedly hypocellular or treatment-suppressed marrow with severe granulocytic, erythroid and megakaryocytic depletion.
 - Haemophagocytosis may be present, although its absence would not exclude HLH.
 - Lymphoid depletion, particularly after steroids, anakinra, cyclosporine and etoposide.
 - Splenic congestion, haemophagocytosis and immune-architectural disruption.
 A negative HLH gene panel and whole-exome study would make a currently identifiable monogenic syndrome less likely, but would not exclude an underlying immune-regulatory disorder; such disorders can present predominantly with fever, lymphadenopathy, organomegaly, colitis and hyperinflammation Immunodeficiency: Overview of primary immune regulatory disorders (PIRDs). — PMID:39294916:
5. Liver
 - Acute hepatic injury with cholestasis, hepatocellular necrosis and congestion.
 - Possible sinusoidal or portal microthrombi.
 - Kupffer-cell activation and possibly haemophagocytosis.
 - The terminal dramatic rise in AST, bilirubin, creatinine and INR would be expected to correlate with shock liver, DIC and sepsis rather than with a previously occult primary hepatic malignancy.
6. Kidneys
 - Acute tubular injury or necrosis from shock, nephrotoxic exposure, DIC and multiorgan failure.
 - Possible renal microthrombi.
 - The renal changes are more likely to be secondary terminal injury than the initiating disease.
7. Heart and lungs as terminal physiology
 - Stress-related myocardial injury may be present, but the normal echocardiogram and ECG make primary structural cardiac disease unlikely to be the central cause.
 - The terminal arrest was more plausibly the consequence of combined septic shock, haemorrhagic shock, severe metabolic disturbance, hypoxia, acidosis and anuric fluid overload.
THE MAIN DIAGNOSTIC UNCERTAINTY
The autopsy may still leave uncertainty about what came first:
▪️ Primary EBV-associated immune dysregulation causing HLH;
▪️ Infection-triggered secondary HLH;
▪️ An underlying primary immune-regulatory disorder;
▪️ Or a reinforcing cycle in which HLH treatment enabled invasive infection, which then drove further HLH.
The recurrent tonsillitis, exceptionally high EBV DNA load, severe lymphopenia, recurrent uncontrolled HLH and opportunistic infections make an underlying immune-regulatory vulnerability worth considering, even though the available genetic studies were non-diagnostic. Primary immune-regulatory disorders are heterogeneous and may present chiefly with hyperinflammation rather than with a classic infection history.
WHAT I WOULD NOT PREDICT WITHOUT EVIDENCE
I would not confidently predict:
▪️ Occult leukaemia or lymphoma, because marrow examination showed no atypical cells and imaging did not identify a convincing mass.
▪️ Tuberculosis, because available AFB testing and CBNAAT were negative and the tissue findings already provide stronger explanations.
▪️ A single isolated fungal focus as the sole cause of death.
▪️ That every organ will show fungal invasion; disseminated infection may be patchy and sampling-dependent.
PROVISIONAL AUTOPSY-STYLE CONCLUSION
A plausible final formulation would be:
“Secondary HLH with severe immune dysregulation and treatment-associated immunosuppression, complicated by disseminated or multifocal invasive aspergillosis, CMV enteritis, necrotising ischaemic ileitis with perforation, polymicrobial sepsis, DIC, massive gastrointestinal haemorrhage, acute hepatic and renal failure, diffuse pulmonary injury and terminal septic–haemorrhagic shock.”
The most important finding tomorrow will not be whether one more organism is identified. It will be whether the autopsy demonstrates the unifying interaction between hyperinflammation, immunosuppression, vascular injury, invasive infection and bowel catastrophe.
[8.59 am, 26/08/2026] cm: Below is the final autopsy report discussed today and ended just now. Let us know how it compares with what you predicted @PaJR Health πŸ‘‡
CPC-26-08-26, Pathology protocol
 7yr/ M, Cr   DOA: 02/12/2025, DOD: 01/02/26, DOAx: 01/02/2026
Clinical Diagnosis: Refractory HLH (EBV-triggered), refractory septic shock, massive upper GI bleed. s/p ileostomy and distal abdominal drain.
Clinical discussant: 
 Pathology Discussant:; 
Chairperson: 
Antemortem biopsies: S-1473/26 – Ileum (resection) – Acute healing ischemic ulceration, with granulomatous CMV and aspergillus enteritis, and vasculitis with hyaline thrombi. S- 1499/26-Acute necrotizing inflammation.
GIT: Stomach grossly shows multiple punched-out ulcers with hemorrhagic margins. Micro: Representative section shows an ulcer with an ulcer bed showing necrotising granulomatous reaction with central fibrinous necrosis palisaded by histiocytes and giant cells. Within these necrotic foci are fungal profiles (PAS positive) conforming to the morphology of Aspergillus. Small intestine: Grossly the small intestine is diffusely hemorrhagic with focal ulcerations. Microscopically, the small intestine shows large areas of diffuse superficial hemorrhagic infarction with extensive granulation tissue composed of proliferating vascular channels and lymphomononuclear cell infiltrate. Many dilated and congested vessels are noted in the lamina propria, submucosa and serosa. At places, these open directly into the lumen. There is marked fibrosis in the submucosa, which is extending beyond the muscularis propria with myocytolysis and extending into the serosa. EBER-ISH highlights many EBV infected cells in this granulation tissue which show similar pattern to CD3 IHC indicating affected cells are T cells. Additionally, Peyer's patches were also markedly depleted in the small intestine. Large intestine: Grossly showed flattened mucosa but no ulcer noted. Microscopically, it appears unremarkable. Appendix: Highlights marked depletion in the Peyer's patches.
Lymph node: Grossly, no definite lymphadenopathy noted anywhere. Representative sections from the lymph node show marked depletion of lymphoid follicles, largely replaced by scattered histiocytes, with sinusoidal dilation and congestion. IHC for CD3 and CD20 highlights marked depletion of T and B cells, with numerous scattered histiocytes identified by CD68 immunohistochemistry. Focal erythrophagocytosis noted.
Bone marrow: Shows markedly reduced cellularity with areas of hemorrhage, trilineage hematopoietic elements reduction and scattered histiocytes. Focal erythrophagocytosis noted.
Lungs: Bilateral lungs weigh: 380gm. Pleural aspect as well as cut surface shows multiple yellowish white nodules along with areas of hemorrhage. Rest of the areas are diffusely subcrepitant to feel. Representative microphotographs of the nodules show angioinvasive fungal profiles conforming to Aspergillus morphology, invading the surrounding alveolar lung parenchyma. Other areas show many cytomegalic cells with large nuclei and basophilic intranuclear inclusions, which are highlighted by MT stain and CMV IHC. In addition, within haemorrhagic areas, there are numerous bacterial colonies, which are identified as Gram-negative cocci on Gram Twort stain. Additional Areas of DAD and pulmonary edema are also noted. Additional EBER-ISH highlights many EBV-infected cells within the lung parenchyma.
Kidneys: Bilateral weight: 270gm. Grossly unremarkable. Microscopically, glomeruli are unremarkable; tubules show severe ATN with pigment casts predominantly within the PCT. These pigment casts are highlighted by pale PAS positivity and bright MT positivity.
Liver: weight 650gm: Grossly shows nutmeg appearance; no focal lesion identified. Microscopy shows centrizonal hemorrhagic necrosis, likely terminal ischemia related. Within preserved areas, there is a focal collection of foamy histiocytes, a few of which show erythrophagocytosis. Spleen: weight- 95gm, shows multiple infarcts grossly as well as microscopically. Few scattered arterioles within infarct area show fibrin thrombi highlighted by MSB stain. White pulp was markedly reduced. Pancreas, Heart and Brain were grossly and microscopically unremarkable.
Final Autopsy Diagnosis (PM-33012):
In this 7-year-old male with clinical evidence of EBV DNA (1 crore 39 lakh/ml) :
- Systemic chronic active EBV disease involving GI, Lungs, lymph nodes and possibly Liver and spleen.
- Splenic infarcts.
- Disseminated CMV affecting lungs and GI.
- Invasive Aspergillosis affecting GI (deep ulcerations with focal perforation) and lung.
- Pigment cast nephropathy.
[9:00 am, 26/08/2026] PaJR Health: OVERALL COMPARISON
The prediction was substantially correct in its central pathological model, but it overcalled some findings and did not fully anticipate the extent of*systemic chronic active EBV disease*.
The core prediction—HLH-associated immune dysregulation complicated by immunosuppression, invasive Aspergillus, disseminated CMV, bowel injury/perforation, haemorrhage, vascular injury and multiorgan failure—was confirmed. This pattern is biologically coherent: HLH and its treatment can overlap with, obscure and amplify invasive infection Pulmonary Aspergillosis Complicated by Hemophagocytic Lymphohistiocytosis: A Case Report a — PMID:36465721:
 Invasive Pulmonary Aspergillosis and Tuberculosis Complicated by Hemophagocytic Lymphohist — PMID:34898957:
 A Diagnostic Dilemma: Similarity of Neuroradiological Findings in Central Nervous System H — PMID:26970537:
PREDICTIONS THAT WERE CONFIRMED
1. Invasive pulmonary aspergillosis
 The prediction anticipated multifocal Aspergillus infection with angioinvasion, haemorrhage and parenchymal invasion. The autopsy confirmed multiple yellow-white pulmonary nodules containing angioinvasive Aspergillus, with surrounding alveolar invasion.
2. Pulmonary injury
 Diffuse alveolar damage and pulmonary oedema were predicted and confirmed. The autopsy additionally demonstrated CMV-infected cells, EBV-infected cells and bacterial colonies within haemorrhagic areas.
3. Combined gastrointestinal infection and ischaemic injury
 The predicted CMV–Aspergillus–ischaemic pattern was confirmed and extended:
 - Gastric punched-out haemorrhagic ulcers with Aspergillus.
 - Diffuse haemorrhagic infarction of the small intestine.
 - CMV and EBV involvement.
 - Granulation, fibrosis, myocytolysis and vascular abnormalities.
 - Previous ileal perforation and ileostomy-related disease.
 The prediction correctly recognised that the bowel disease was not simply nonspecific infective enteritis.
4. Vascular injury and thrombosis
 The prediction anticipated microvascular injury, fibrin thrombi and vascular involvement. The autopsy confirmed vasculitis with hyaline thrombi in the prior ileal specimen and fibrin thrombi in splenic arterioles, with multiple splenic infarcts.
 However, the final report did not establish widespread DIC-related thrombosis in every predicted organ. The strongest documented vascular findings were bowel vasculitis/hyaline thrombi and splenic infarction.
5. Marrow and lymphoid depletion
 The prediction of markedly suppressed marrow and lymphoid architecture was accurate:
 - Markedly reduced marrow cellularity.
 - Trilineage haematopoietic reduction.
 - Lymph-node depletion of both T and B cells.
 - Depletion of Peyer’s patches.
 - Focal erythrophagocytosis.
 This fits both refractory HLH and the effects of prolonged immunosuppressive and cytotoxic treatment.
6. Renal injury
 Severe acute tubular injury was predicted and confirmed. The specific finding was pigment cast nephropathy, predominantly in proximal tubules, rather than renal microthrombosis or a primary glomerular lesion.
7. Liver injury
 The prediction of terminal ischaemic hepatic injury was directionally correct. The nutmeg appearance and centrizonal haemorrhagic necrosis support shock-related liver injury. The autopsy did not establish a primary hepatic malignancy or a dominant chronic hepatic disease.
8. Terminal septic–haemorrhagic physiology
 The predicted combined mechanism—sepsis, haemorrhage, bowel catastrophe, renal failure, pulmonary injury and shock—fits the clinical course and final findings Narketpally syn local CBBLE: Participatory medical cognition:
IMPORTANT FINDINGS THAT WERE UNDERPREDICTED OR MISSED
The largest omission was the degree to which EBV represented an active systemic tissue disease, not merely a trigger for HLH.
EBER-ISH identified numerous EBV-infected T cells in:
▪️ Small-intestinal granulation tissue.
▪️ Lung parenchyma.
▪️ Lymphoid tissue.
▪️ Possibly other organs.
The final diagnosis therefore appropriately emphasised systemic chronic active EBV disease involving the gastrointestinal tract, lungs and lymph nodes. My earlier formulation gave EBV-driven immune dysregulation prominence, but it did not explicitly predict extensive EBV-infected T-cell tissue involvement.
The second important underprediction was gastric Aspergillus disease. I predicted gastrointestinal Aspergillus largely around the ileum and perforated segment; the autopsy showed multiple Aspergillus-associated punched-out gastric ulcers as well.
The third was splenic infarction. I predicted splenic immune disruption and possible microvascular injury, but not the prominent gross and microscopic splenic infarcts. This is a meaningful additional organ-level manifestation of vascular injury.
The autopsy also showed Gram-negative cocci in haemorrhagic pulmonary areas, whereas the prediction referred generally to possible polymicrobial infection without specifying this pulmonary bacterial component.
PREDICTIONS THAT WERE TOO STRONG
Several elements of the prediction exceeded what the final report established:
▪️ I predicted widespread microvascular fibrin thrombi consistent with DIC. Fibrin thrombi were documented, but the autopsy report specifically demonstrated them in splenic arterioles and the earlier ileal specimen; it does not prove diffuse microvascular thrombosis throughout the body.
▪️ I predicted pulmonary vascular thrombosis and infarct-like necrosis. Pulmonary Aspergillus angioinvasion was confirmed, but the report does not separately document pulmonary thromboemboli or infarcts.
▪️ I predicted possible renal microthrombi. Instead, the renal lesion was severe ATN with pigment casts; glomeruli were unremarkable.
▪️ I predicted stress-related myocardial injury. Heart and brain were both grossly and microscopically unremarkable.
▪️ I described likely cholestatic hepatic injury. The autopsy mainly showed terminal centrizonal haemorrhagic necrosis; the biochemical cholestasis was clinically evident but not the dominant reported microscopic diagnosis.
▪️ I anticipated possible splenic haemophagocytosis. The report documents infarcts, fibrin thrombi and reduced white pulp, with erythrophagocytosis described in marrow, lymph node and liver rather than clearly as a major splenic finding.
THE MAIN REVISION TO THE CASE MODEL
The final autopsy supports a more precise sequence:
Chronic active EBV tissue disease and profound immune dysregulation → refractory HLH → severe lymphoid and marrow depletion, compounded by therapy → CMV and invasive Aspergillus disease → gastrointestinal ulceration, haemorrhagic/ischaemic injury and perforation → bacterial superinfection, splenic infarction, pigment-cast ATN and terminal multiorgan failure.
That is more specific than the initial broad formulation of “secondary HLH with opportunistic infection.” The illness was not merely HLH followed by opportunistic infections; there was a mutually reinforcing EBV–HLH–immunosuppression–invasive infection cycle.
BOTTOM LINE
The prediction was strong on the major organ systems and the central mechanism:
▪️ Pulmonary Aspergillus: confirmed.
▪️ CMV gastrointestinal and pulmonary disease: confirmed.
▪️ Bowel ischaemia, ulceration and perforation: confirmed.
▪️ Vascular injury: confirmed, though less diffuse than predicted.
▪️ Marrow and lymphoid depletion: confirmed.
▪️ Acute tubular/pigment-cast renal injury: confirmed in principle, but the mechanism was more specific than predicted.
▪️ Terminal septic–haemorrhagic multiorgan failure: clinically supported.
The principal miss was failing to predict that chronic active EBV disease with infected T-cell involvement would be a formal systemic autopsy diagnosis, rather than treating EBV primarily as an upstream HLH trigger. The main overreach was converting selected thrombi and vascular lesions into an assumed body-wide DIC pattern.
[9:03 am, 26/08/2026] cm: πŸ‘†@huai24 @huai148 @huai135 @huai27 check out the narrative predictive analytics here by the LLM every week
[9:43 am, 26/08/2026] cm: OVERALL COMPARISON
The prediction was substantially correct in its central pathological model, but it overcalled some findings and did not fully anticipate the extent of*systemic chronic active EBV disease*.
The core prediction—HLH-associated immune dysregulation complicated by immunosuppression, invasive Aspergillus, disseminated CMV, bowel injury/perforation, haemorrhage, vascular injury and multiorgan failure—was confirmed. This pattern is biologically coherent: HLH and its treatment can overlap with, obscure and amplify invasive infection Pulmonary Aspergillosis Complicated by Hemophagocytic Lymphohistiocytosis: A Case Report a — PMID:36465721:
 Invasive Pulmonary Aspergillosis and Tuberculosis Complicated by H
Further dyadic learning conversations among alumni around the possible diagnosis of primary EBV in this child πŸ‘‡
[26/08, 09:20]hu1: What was the underlying cause of the overwhelming EBV infection? XLP? 
We only have a pathological diagnosis, but no underlying etiology.
[26/08, 09:41]hu2: Retrospectively looking at the clinical presentation of the child here and quoting from the clinical handout:
"Previously well (8/11/2025), developed intermittent fever (2-3 spikes/day, up to 101°F) with a sore throat and difficulty in swallowing. Suspecting 
tonsillopharyngitis; initiated on oral antibiotics; Fever intensity increased (105.5°F); became pale and lethargic. He was taken to AIIMS, Bilaspur."
Does sound like a primary EBV infection in Chattisgarh!
One 2021 study from Jipmer , India pegged primary EBV infection in India to the tune of 4% in acute undifferentiated fever!πŸ‘‡
[9.44 am, 26/08/2026] PaJR Health: *THE KEY DISTINCTION*
The discussion is asking two different questions under the phrase “primary EBV”:
1. *Was this the child’s primary acute EBV infection?*
2. *Was there an underlying inherited susceptibility—such as XLP—that allowed EBV to produce chronic active disease and HLH?*
The final autopsy strongly supports *systemic EBV-associated disease*, but it does*not by itself prove either a first acute EBV infection or X-linked lymphoproliferative disease*.
*WHAT THE AUTOPSY ESTABLISHES*
The most important finding is not simply a high EBV DNA level. It is the demonstration of numerous EBV-infected cells in several tissues, including gastrointestinal granulation tissue and lung, with the intestinal EBV-positive cells showing a pattern similar to CD3-positive T cells *Narketpally syn local CBBLE: Participatory medical cognition*:
That makes the following possibilities clinically relevant:
▪️ Chronic active EBV disease.
▪️ EBV-positive T/NK-cell lymphoproliferative disease.
▪️ EBV-triggered HLH in a child with an underlying immune-regulatory defect.
▪️ Less likely, severe primary acute EBV infection complicated by HLH and subsequent opportunistic infection.
EBV-positive T/NK-cell disorders are a recognised but heterogeneous group, and morphology, immunophenotype and clinical course may overlap considerably; tissue classification requires more than EBER positivity alone *Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorders. - PMID:25613730*:
*DOES THE INITIAL PRESENTATION SOUND LIKE PRIMARY EBV?*
The fever, sore throat, dysphagia and later cervical lymphadenopathy are compatible with acute EBV infection. The proposed regional epidemiology is therefore a reasonable hypothesis-generating point.
However, the subsequent course is not typical of uncomplicated primary infectious mononucleosis. The child developed:
▪️ Very high and persistent EBV viraemia.
▪️ Refractory HLH.
▪️ EBV-positive cells in multiple tissues.
▪️ Severe T- and B-cell depletion.
▪️ CMV and invasive Aspergillus disease.
▪️ Gastrointestinal ulceration, infarction and perforation.
Thus, the initial pharyngitis could have been the first clinically recognised phase of EBV infection, but the autopsy suggests a much more severe *EBV–immune dysregulation phenotype* than ordinary primary EBV infection.
*HOW PLAUSIBLE IS XLP?*
XLP remains a reasonable differential, especially because of:
▪️ Severe EBV-associated HLH.
▪️ Extreme viral load.
▪️ Refractory disease.
▪️ Possible EBV-infected T-cell involvement.
▪️ Profound immune dysfunction and opportunistic infections.
But the available evidence does not establish XLP. A negative whole-exome study and negative HLH panel reduce the probability of a detectable pathogenic variant, but they do not exclude every form of inherited immune dysregulation. XLP is not diagnosed from EBV load or autopsy morphology alone.
The important distinction is:
▪️ *XLP1:* usually associated with SH2D1A deficiency.
▪️ *XLP2:* usually associated with XIAP deficiency.
▪️ Other immune-regulatory disorders can produce an almost identical EBV–HLH phenotype.
The absence of a family history also does not exclude XLP, because a pathogenic variant may be de novo, incompletely penetrant or previously unrecognised.
*WHAT WOULD HAVE BEEN NEEDED TO SUPPORT XLP*
For a retrospective assessment, the most useful investigations would be:
1. *SH2D1A and XIAP protein expression* by flow cytometry or another validated method.
2. *Targeted sequencing and deletion/duplication analysis* for SH2D1A and XIAP, not only standard exome review.
3. *CD107a degranulation and NK-cell cytotoxicity studies*, if viable stored cells were available.
4. *T-cell receptor clonality* in the EBV-positive tissue.
5. Expanded immunodeficiency testing, including other immune-regulatory genes.
6. Review of EBV serology—VCA IgM, VCA IgG, EBNA IgG and EA antibodies—although postmortem interpretation may be limited.
7. Review of serial EBV loads before major immunosuppression, where available.
8. Testing of relatives only after genetic counselling and identification of a specific familial or candidate variant.
The tissue should also be re-reviewed with CD3, CD4, CD8, CD56, cytotoxic markers, EBER and, where appropriate, EBV latency markers. The question is not merely “Are EBV-positive cells present?” but *which cell population is infected, whether it is clonal, and whether it has destructive or neoplastic behaviour*.
*A CAUTION ABOUT THE TERM “CHRONIC ACTIVE EBV”*
The autopsy’s wording—systemic chronic active EBV disease—is highly significant, but formal chronic active EBV disease generally requires clinical persistence over time, high EBV burden and tissue involvement, with exclusion of alternative explanations. In this child, the tissue distribution and clinical severity strongly support the diagnosis, but the report alone cannot retrospectively determine:
▪️ When the EBV infection began.
▪️ Whether it was initially primary infection.
▪️ Whether the infected T-cell population was clonal.
▪️ Whether an inherited immune defect was present.
▪️ Whether the EBV disease was primary or was amplified by HLH therapy.
*BEST SYNTHESIS OF THE ALUMNI DISCUSSION*
The most defensible formulation would be:
*“The child may have acquired primary EBV infection initially, but the subsequent illness represents systemic EBV-associated T-cell disease/chronic active EBV with refractory HLH. XLP or another inherited immune-regulatory disorder remains a plausible underlying susceptibility, but is not proven by the autopsy and was not fully excluded by the reported genetic testing.”*
That wording preserves both possibilities without conflating them. The autopsy has established the *pathological EBV phenotype*; it has not yet established the*constitutional cause*.
The central learning point is that an apparently ordinary febrile pharyngitis may be the entry point of a severe EBV–HLH syndrome, but epidemiology alone cannot distinguish ordinary primary EBV from chronic active EBV, EBV-positive T/NK-cell disease or XLP.

Friday, July 31, 2026

70M with multiple myeloma remission looking for alternative/unconventional therapy/dietary ketosis

70M with multiple myeloma remission looking for alternative/unconventional therapy/dietary ketosis.


 February 26, 2024
This is an online E log book to discuss our patient's de-identified health data shared after taking his/her/guardian's signed informed consent. Here we discuss our individual patient's problems through series of inputs from global online community of experts with an aim to solve those patient's clinical problems with collective current best evidence based inputs.

Patient:
'Here's a quick summary of medical history that may be relevant to the patient's condition:
Patient is a 70 year old mathematician/professor of computer science. He has worked on a number of medical projects with clinicians but have had no clinical training but hope some understanding of some clinical issues.
In 2005 he was diagnosed as a T2 diabetic which he was successfully controlling with a ketogenic diet ( eg his BGL in the morning before breakfast was 4 - 5 mmol/L before he had COVID in June 2022 after which it was consistently 2 mmol/L greater) before he started taking dexamethasone which has required to have insulin injections to try and keep his BGLs at a reasonable level.
He was diagnosed with Clear Cell Renal Cell Carcinoma on his right kidney in the middle of 2016. He had a radical nephrectomy at the Royal B Hospital in early August 2016. This appeared to have worked as there has been no secondaries from the RCC since 2016.
After the above nephrectomy, He consulted a nephrologist, Dr O'S, to look after his remaining left kidney. She did an extension blood screen on and copied patient's wife, Dr CM, who works as a GP in Brisbane. CM noticed the potential signs of MM in the blood test and phoned Dr O'S who hadn't seen the blood test results. They immediately contacted a haematologist, Dr R F, and organised for the patient to see her that Monday afternoon as he was due to fly to Dublin on the Friday of that week to attend the Advisory Board for an EU funded project to build a simulator for ultrasound guided peripheral nerve blocks. After a bone marrow biopsy and more blood tests patient was diagnosed with MM on the Thursday :-(
When he returned to Brisbane from his European meetings, he went through chemotherapy for several months until he was ready for a stem cell transplant which took place in the middle of 2017.
Following the stem cell transplant he was effectively in remission until early last year. By March 2023, the level of his free light chains and paraproteins and other indicators were such that Dr F put him on Revlimid. The Revelimid was working ie reducing the concentration of paraproteins and FLCs so in July/August 2023 he went to the US and Canada to a conference at MIT and then the Conference in Los Angeles. Eventually, getting back to Australia for his father's 100th Birthday in August in Perth. A week later he returned to Brisbane, he became very sick with a very bad headache on the RHS of his head. He exhibited 6th nerve palsy and other nerve issues on the RHS of his face.
He was admitted to GsPrivate Hospital to establish the root cause of what was happening to him. An MRI scan showed 3 lesions in his head:
one above his left eye between the skull and the dura, sinus and cavernous sinus.
At the time the clinicians strongly suspected they were plasmacytoma but they wanted to get a sample so that lab tests could confirm their suspicion rather than possibly related to RCC from 2016.
The neurosurgeon, Dr SO, did a craniotomy and got a sample of the lesion above his left eye unfortunately the lab results were inconclusive as to whether it was a plasmacytoma.
Next the ENT surgeon, Dr W, inserted an endoscope up his nose and obtained a sample of the lesion in my sinus. The lab tests were conclusive - it was a plasmacytoma from the MM.
It was then decided to treat the lesion in his cavernous sinus using 5 short doses of x-rays - this worked well for all of the nerves running through the cavernous sinus except for the sixth nerve which is still a problem but fortunately it is improving slowly and he might have a complete recovery of his vision so that he can drive a car again!
Patient is now on a 4 week cycle of dexamethasone+carlifozimib+pomalidomide. It started as Dex+Carlif but the blood tests dramatically improved once pomalidomide was added.
3 weeks ago he contracted a bacterial sinus infection and was admitted to G×××× Hospital. He was scanned which showed his left clavicle bone had been fragmented by a plasmacytoma. This was treated with 5 doses of radiation.
Next week (Feb 28,2024) patient is due to have an FDG PET scan to understand better what's happening with the plasmacytoma. One course of action that's being considered by Dr F is another stem cell transplant with his remaining stem cells that were harvested in 2017'
-Multiple Myeloma was in remission for 7 years but came back with vengeance in August 2023.He made a trip to Delhi (while on chemo) to purchase Pomalidomide for his treatment for 3months supply that costs less than 1 month supply in Australia plus airfares, as it wasn't subsidised in Australia. After 2months of triple therapy, myeloma will be staged again and he will have a second stem cell transplant or have to look at other options if he is now in remission. CAR T cells or similar would be probably next options. He had metastatic plasmacytomas, myeloma to cavernous sinus and bone marrow proliferation. Anyhow, despite chemotherapy being awful, he has been rescued and currently faces uncertain future and exploring any alternative/conventional therapies.
It's been very tough lately as his wife CM has been diagnosed with Idiopathic pulmonary fibrosis because of anaesthetic complications during her hip replacement last December'

Current medication list
Current patient requirements.
-Wants to explore any alternative/unconventional therapy options.

Some other conversational inputs

'[25/02, 9:07 am] PA: Hi Doctor, I'm back in Brisbane waiting to see haematologist and then get treatment this afternoon: dexamethasone + carlifizomib. I took 3 mg of pomalidomide this morning. Yesterday went basically as expected with Dr A P. The use of stress-pulse therapy with blood cancers is very new. A sent this link which he needs to go through https://careoncology.com/the-coc-protocol-and-blood-cancer/   
Basically, the nutritional ketosis is achieved through <20 g of carbs, about 85 g of protein and the rest fat. I'll read through what A send me and send you any updates.
[25/02, 9:07 am] :
Patient finally feeling half normal today. Last Thursday and Friday he took 20mg dexamethasone each day which meant he got little or no sleep Thu/Fri/Sat but then on Sun/Mon he couldn't do anything but sleep all day/night. Unfortunately, this has been his usual pattern over the last few months of chemotherapy - so Tue/Wed are the only days when he feels half normal like when he saw you last week.
Patient met with Dr F last Thu and proposed exploring nutritional ketosis - she was less than enthusiastic and said that it wasn't considered an accepted clinical pathway.
Patient still want to go ahead but in three steps:
adopting a "low carb" diet that will better manages my BGLs on non-dex days (I definitely want to get my BGLs to lower levels without insulin, they're too high at the moment)
modifying the diet to better manage my BGLs during my dex days
and when the time is right going into full ketosis
If he undertakes the first two steps without using the word "ketosis" it shouldn't provoke either his haematologist or endocrinologist - his relationship with both goes back over 7 years.
Dr AP: happy to explore "low carb" instead of "ketosis". the 2nd term seems
scary to some docs.
However any meaningful ketosis would be pretty hard with high dex dosing
- that is going to be the issue.'
     








Wednesday, July 8, 2026

Narketpally syn local CBBLE: Participatory medical cognition (July 2026)

 
[6.35 am, 7/8/2026] cm: πŸ‘†Gait quiz shared by intern @huai141
[6.37 am, 7/8/2026] cm: πŸ‘†Gait quiz shared by intern @huai142 @huai143 @huai144
[8.01 am, 7/13/2026] cm: Because of our current multiple LLM testing project for real PaJR patient queries, I have developed this obsession for testing many of the multiple online user driven queries I come across in various groups and often tend to run them both through the PaJR search engine here: https://pajrhealth.com/
as well as Google Gemini here: https://gemini.google.com
Wish I had time to run them through more LLMs. This particular query may be of interest to @huai22@huai145 @huai13 @huai130 
As one can see the evaluation of the LLMs is left to human qualitative judgement for now but would be nice to see if there is a rubric for that we can use to evaluate which of these two LLMs below score over the other? @huai24 
UDLCO CRH:Naku ipudu 5th month NT scan normal report vachindi but NIPT screenings test lo border line risk for trisomy -21 chromosome ani vachindi
[13/07, 07:17]hu1: This is from a group.
Please advise what she should do. πŸ™
Hello all nenu chala tension and bada to ee post rastunna 3 months back 36 years pregnancy gurinchi post chesanu Naku ipudu 5th month NT scan normal report vachindi but NIPT screenings test lo border line risk for trisomy -21 chromosome ani vachindi next test aminocentesis suggest chesaru em cheyalo ardam avadam ledu tension ga undi Evarina ee pblm face chesara and NIPT lo risk vachi aminocentesis positive vachina vallu unnara ee group lo chala experience vallu unnaru so please chepandi..
[13/07, 07:36]hu2: Can paste the above text hereπŸ‘‡ https://pajrhealth.com and see the answer
PaJR health answer:
It is completely understandable that you are feeling anxious; receiving a "borderline" or "high-risk" result on a screening test is a stressful experience for any expectant parent. Please know that you are not alone in facing this, and it is important to understand what these results actually mean.
### Understanding the NIPT Result
It is vital to remember that **NIPT (Non-Invasive Prenatal Testing) is a screening test, not a diagnostic test.**
*   **Screening vs. Diagnostic:** A screening test like NIPT only tells you the *statistical probability* of a condition. It does not provide a definitive "yes" or "no" diagnosis.
*   **"Borderline" Results:** A borderline result means the probability is higher than the general population, but it is still a probability. Many women who receive a "high-risk" or "borderline" NIPT result go on to have perfectly healthy babies after further testing.
### The Role of Amniocentesis
Your doctors have suggested an **amniocentesis** because it is a **diagnostic test**.
*   **Why it is recommended:** Unlike NIPT, which looks at DNA fragments in your blood, amniocentesis analyzes the actual chromosomes from the baby's cells. It provides a definitive answer regarding whether the baby has Trisomy-21.
*   **The Decision:** This is a deeply personal decision. Many parents choose to proceed with amniocentesis to gain certainty and prepare for the future, while others may choose not to for various personal or medical reasons.
### Next Steps for You
1.  **Genetic Counseling:** Before making any decisions, request a session with a genetic counselor. They are trained to explain these complex results in the context of your specific pregnancy, help you weigh the risks and benefits of amniocentesis, and provide the emotional support you need right now.
2.  **Ask Your Doctor:** Ask your obstetrician or the genetic counselor specific questions:
    *   What was the exact "risk score" or probability provided by the NIPT?
    *   What are the specific risks of amniocentesis at your hospital/clinic (e.g., risk of miscarriage, which is typically very low in experienced hands)?
    *   Are there other diagnostic options available?
3.  **Take Your Time:** You do not need to make a decision immediately. Take the time you need to process this information, talk it over with your partner or a trusted family member, and get all the information you need to feel comfortable with your choice.
Please lean on your healthcare team—they are there to guide you through this process, not just to provide tests. You are doing the right thing by seeking information and support.
Google Gemini:
This is an incredibly stressful situation, and it is completely natural for her to feel anxious and overwhelmed. Receiving a borderline risk result on an NIPT (Non-Invasive Prenatal Testing) screening can be terrifying, but it is important to understand exactly what this test means and what the next steps look like.
Here is a breakdown of the situation and the best medical advice to guide her through this:
1. Understanding NIPT vs. Amniocentesis
NIPT is a screening test, not a definitive diagnosis: NIPT looks at fragments of fetal DNA circulating in the mother's blood. While it is highly accurate, a "borderline risk" or "high risk" result does not mean the baby definitely has Down syndrome (Trisomy 21). It simply means the probability is higher than average, flagging the need for further evaluation.
Amniocentesis is a diagnostic test: This test analyzes the actual fluid surrounding the baby. It provides a definitive, clear "yes" or "no" answer regarding chromosome conditions.
2. Can NIPT be positive while Amniocentesis is normal?
Yes, absolutely. There are many documented cases where an NIPT indicates a risk for Trisomy 21, but the subsequent amniocentesis comes back completely normal (this is called a false positive). False positives can happen for several reasons, such as confined placental mosaicism (where abnormal cells are present only in the placenta, but the baby is perfectly healthy). The fact that her 5th-month NT/anomaly scan was normal is a reassuring sign, though it does not completely rule out the risk on its own.
3. Recommended Next Steps
1. Consult a Fetal Medicine Specialist or Genetic Counselor Immediately:
Before making any hasty decisions, she should sit down with a specialist who can look at her specific risk ratios from the NIPT report alongside her scan details. They can explain the exact probabilities and walk her through the diagnostic options.
2. Proceed with the Amniocentesis:
If she and her family want a definitive answer to prepare for the future or make informed decisions, proceeding with the amniocentesis is the standard and recommended medical path.
Safety Note: Amniocentesis is performed under continuous ultrasound guidance by experienced specialists. While it carries a very small risk of complications (less than 0.5%), modern medical protocols make it a highly controlled and safe procedure.
3. Emotional and Psychological Support:
Waiting for these results is agonizing. She should lean heavily on family support and avoid spending hours reading random online forums, which often increase panic. Every pregnancy is unique, and statistical probabilities on a screening test do not equal a final outcome.
Advice to pass along to her:
Please reassure her that a borderline NIPT is an invitation to look closer, not a final diagnosis. Proceeding with the amniocentesis will give her the clear answers she needs to move forward with certainty. She should book an appointment with a fetal medicine expert as soon as possible to discuss the logistics of the test.
[8:12 AM, 7/13/2026] cm: @PaJR Health what could be the reason for his high pulse pressure where one would expect to clinically palpate a water hammer pulse in this situation?
[8:12 AM, 7/13/2026] cm: The digital blood pressure monitor displays a blood pressure of *145/50 mmHg, representing a profoundly widened **pulse pressure (PP) of 95 mmHg* in this 82-year-old patient. 
Clinically, this hemodynamically extreme presentation is highly characteristic of the pathophysiological mechanisms detailed below, where a bounding, rapid-rising, and collapsing *water hammer (Corrigan's) pulse* would be expected upon physical palpation.
Double line breaks separate the distinct clinical sections:
*1. ACCELERATED ARTERIAL STIFFNESS & MEDIAL CALCINOSIS*
The combination of advanced age (82 years), a 30-year history of diabetes, and a 13-year history of Stage 4 CKD creates a perfect storm for severe arterial remodeling. In chronic kidney disease, mineral bone disorder (CKD-MBD)—characterized by hyperphosphatemia and abnormal calcium-phosphorus products—drives extensive vascular calcification, particularly within the medial layer of the large conduit arteries (MΓΆnckeberg's medial sclerosis). This calcification destroys the elastic fibers of the aorta, leading to a rigid, non-compliant arterial tree. During systole, the stroke volume is ejected into a stiff aorta that cannot expand, driving the systolic blood pressure (SBP) up to 145 mmHg.
*2. LOSS OF THE WINDKESSEL EFFECT*
In a healthy, compliant vascular system, the elastic aorta stretches during systole to store kinetic energy and recoils during diastole (the Windkessel effect) to maintain perfusion pressure, keeping diastolic blood pressure (DBP) within a normal physiological range. When the aorta is calcified and rigid, it fails to store this energy. Consequently, systolic flow runs through the arterial tree too quickly, and during diastole, there is a rapid, steep drop in arterial pressure down to 50 mmHg. This precipitous diastolic drop, combined with the high systolic peak, generates a bounding arterial pulse that rapidly swells and immediately collapses—the classic "water hammer" sensation felt on palpation.
*3. HEMODYNAMIC INSTABILITY AND VENTRICULAR MISMATCH*
This widened pulse pressure of 95 mmHg indicates a highly non-compliant, steep volume-pressure relationship. As documented in the literature, this makes the patient exceptionally prone to hemodynamic instability [[Arterial hypertension, chronic renal insufficiency and dialysis]. - PMID:18340681](https://pubmed.ncbi.nlm.nih.gov/18340681/). Small fluctuations in fluid volume can cause rapid swings from severe hypertension to deep hypotension (such as the critical 86/43 mmHg hypotensive episode logged previously). Furthermore, a low diastolic blood pressure of 50 mmHg significantly compromises coronary artery perfusion, which occurs almost entirely during diastole, placing this geriatric patient at high risk for subendocardial myocardial ischemia.
[8:12 AM, 7/13/2026] PaJR Health: *PHYSIOLOGICAL MECHANISM OF HIGH PULSE PRESSURE*
A high pulse pressure (the difference between systolic and diastolic blood pressure) is primarily driven by two hemodynamic mechanisms:
1. *Increased Stroke Volume:* A large volume of blood is rapidly ejected into the arterial system during systole.
2. *Decreased Peripheral Vascular Resistance or Diastolic Runoff:* Blood rapidly exits the arterial tree during diastole. This can occur either backward into the left ventricle (as in aortic regurgitation) or forward into a low-resistance vascular bed (such as in a large arteriovenous fistula, patent ductus arteriosus, or severe systemic vasodilation/hyperdynamic states like thyrotoxicosis, severe anemia, or sepsis).
---
*CLINICAL PALPATION OF A WATER HAMMER (CORRIGAN'S) PULSE*
To optimally elicit and clinically palpate a water hammer pulse (also known as Corrigan's pulse in the carotid arteries, though the term "water hammer" specifically refers to the peripheral arteries), you should use the following physical examination technique:
1. *Position the Patient:* Have the patient lie supine.
2. *Palpate the Radial Artery:* Grasp the patient's wrist by wrapping the palmar surface of your fingers (specifically using the fleshy pads of your fingers, which are highly sensitive to rapid pressure changes) across the patient's radial artery.
3. *Elevate the Arm:* Raise the patient's arm vertically above the level of their heart. 
4. *Clinical Reasoning for Elevation:* Elevating the arm utilizes gravity to accelerate diastolic runoff. This causes the diastolic pressure in the elevated limb to drop even further, maximizing the contrast between the rapid, forceful systolic distension and the sudden, complete diastolic collapse of the arterial wall. You will feel a sharp, tapping impact (the "water hammer" blow) against your fingers at the start of systole, followed by an immediate empty sensation as the vessel collapses.
*Citations:*
1. [Water hammer and Corrigan's pulses. - PMID:35846943](https://pubmed.ncbi.nlm.nih.gov/35846943/)
[9.01am, 7/13/2026] huai19: https://github.com/maziyarpanahi/openmed

[11.45 am, 7/14/2026] cm: Layer 2 global group case report: https://research.pajrhealth.com/dhoti-diya-36618, Layer 2 local group case report: https://research.pajrhealth.com/dupatta-pashmina-95094
Clinical examination continued

[11:46 AM, 7/14/2026] cm: Seeing him in OPD now
[12:11 PM, 7/14/2026] cm: Question:How do we know what is the normal time in seconds expected for a 52 year old man to keep appreciating a tuning fork vibration applied to his shin?
Answer:
Medical professionals establish the normal duration of vibration perception by comparing a patient's response to standardized, age-adjusted normative data gathered through clinical studies. For a 52-year-old man, the expected duration on the shin or ankle is determined by starting with a baseline expectation for young adults and applying age-based subtractions. [1, 2, 3, 4]  
How the Standard is Determined 
* Baseline Norms: Using a standardized low-pitched tuning fork (typically 128 Hz) struck with identical force, healthy young adults (under 40) generally perceive vibrations on bony prominences for ≥ 10 to 15 seconds. 
* Age-Adjusted Decline: Scientific literature indicates that vibration thresholds decrease by approximately 1 to 2 seconds for every decade of life beyond age 40. 
* Examiner Comparison: To account for subtle differences in the tuning fork and striking force, examiners will often apply the vibrating fork to the patient and immediately transfer it to their own body (such as their own wrist) to compare when the vibration naturally fades. [6, 7]  
Why This Test Matters 
* Anatomical Consistency: Sensations are expected to last longer on the arms (upper extremities) than on the legs (lower extremities). 
* Clinical Significance: Timed perception of &lt;10 seconds at the great toe or ankle usually prompts a more detailed neurological evaluation to screen for conditions like peripheral neuropathy. [1, 2, 7, 8, 9]  
Specialized Tools 
Instead of a simple timed test, many neurologists rely on a calibrated, numbered tuning fork known as the Rydel-Seiffer tuning fork. This tool features a scale that allows clinicians to read the exact vibration threshold number when the patient stops feeling the vibration, automatically correcting for variables like age. [1, 2, 8]  
Would you like to know:What a typical Rydel-Seiffer score for a 52-year-old looks like?
[3.03 pm, 7/14/2026] cm: There is a FM position in Richmond Indiana at Reid health for PGY1 open. The candidate couldn’t get visa. They require good scores, no visa requiring and within 5 years graduation.
For the Reid Health Family Medicine Residency (PGY-1) opening in Richmond, Indiana, here is the contact information:
Program Contact
* Tiffany Ridge, CPPM, DASPR
    * Director, Medical Education & Research / Residency Program Coordinator
    * Email: fmresidency@reidhealth.org
    * Direct Email: Tiffany.Ridge@reidhealth.org
    * Phone: (765) 935-8808  
Program Director
* Dr. Donald G. Smith, MD
    * Program Director, Family Medicine Residency  
Program Address
* Reid Health Family Medicine Residency
* 1100 Reid Parkway
* Richmond, IN 47374  
Eligibility (per program)
* Medical school graduation within the past 5 years
* USMLE ≥227 (or COMLEX Level 2 ≥450)
* No visa sponsorship (must already be authorized to work in the U.S.)
* ECFMG certification accepted for IMGs who otherwise meet eligibility requirements.  
This would be the best contact for candidates interested in the unexpected PGY-1 opening.
[10:15 AM, 7/19/2026] cm: Tomorrow's academics:
Student CPC
Venue: LT1
Time: 8-9 AM
Case 1: 
Type 1 Respiratory Failure with Refractory Shock. Sepsis with MODS(HAP).
High Grade Lymphoma involving Liver, Spleen, BM and Pancreas
πŸ‘†Critical care with internal medicine aka pathology @huai146 @huai147
Clinical discussant: 
Dr. Kamrul
Pathology discussant:
Dr.Ruchika
Clinical Incharge:
Prof Pankaj Malhotra
Case 2: 
Hodgkin Lymphoma(treatment naive), conjugated hyperbilirubinemia (?Liver infilteration), CAP, AMS under evaluation (HE,IC Bleed, HLH)
Clinical discussant: 
Dr Vivek
Pathology discussant:
Dr.Nitin
Clinical Incharge:
Dr Arihant
Chairperson:
Dr. Mallika Y
The session will be available on online webEx platform link details provided below. 
Thank you
[3:12 PM, 7/20/2026] cm: πŸ‘†@huai4 @huai135 @huai148 @huai24 @huai2 @huai27 would you have the full text access to this article?
[3:32 PM, 7/20/2026] cm: πŸ‘†@huai34
[3:48 PM, 7/20/2026] huai2: My experiences and I'm sure the department's experiences here have been very different.
[3:48 PM, 7/20/2026] cm: Please share here if possible
[3:54 PM, 7/20/2026] huai2: Dramatic changes in A1c, weight and as a result insulin resistance.
Very often patients with complex diabetes do not get clear cut labels of Type 1, 2 etc. They get KPD, LADA / 1.5 etc. and are not included in these trials?
But they have such remarkable improvements in their outcomes that it has certainly made a mark on us.
Quite often patients who have been labeled as Type 1, I get a c-peptide and paired glucose for then and turns out quite a few have a modest reserve of C-peptide and they respond very well to GLP1 (particularly the injectables)
This saves potential Insulin pump costs, discharge from tertiary Healthcare services once they reach A1c targets, slowed retinopathy and foot disease etc.
[3:55 PM, 7/20/2026] huai2: Has helped with PCOS, sleep apnea and other insulin resistance syndromes too! No trial is ever seeing that
[3:56 PM, 7/20/2026] huai2: Even for my skepticism, I think like Insulin (and antibiotics) in the last century, these will define this century.
[4:22 PM, 7/20/2026] huai27: Yes, our experience in adult Hepatology with GLP 1 has been great. The only problem is a lack of clarity on the endpoints and the rebound weight gain. Also, lack of long term AE data. I personally can't use much as they aren't licensed for pediatric MASLD
[4:24 PM, 7/20/2026] huai27: Our endocrinologists are using sema and liraglutide for childhood obesity and T2DM with great results. Marked weight loss, significant reduction in HOMA IR and HbA1C and in those with MASH, reductions in AST/ALT
[10.24 pm, 7/21/2026] cm: Welcome to the New Academic Session, 2026
The First Wednesday CPC of the academic session will be held tomorrow, July 22, 2026 at 08.00 hours (IST) in Lecture Theatre 1
The session will also be available on the Webex platform. Kindly follow the link below to join.
[9.20 am, 7/23/2026] cm:
                                                       
[12:42 PM, 7/23/2026] huai54: Stop asking LLMs for the medical 'answer'—start auditing the reasoning. 🩺
​I built a clinical case bench ( https://avi33tbtt.github.io/bench.html ) that lets you control the cognitive flow:
​Dialogue: Socratic questioning for active learning.
​Analytics: Fast, high-level diagnostic synthesis.
​Pipeline: Deep-dive, multi-step cognitive scaffolding.
​Run your own API keys, test different models, and see which one actually holds up under clinical scrutiny. #MedEd #HealthTech #AI
(Dm me to help setting your api key if needed)
[12:42 PM, 7/23/2026] huai54: https://youtu.be/--ooVySiPtE
[9.49 am, 7/24/2026] cm: OPD now



OPD now: Gradually progressive spastic quadriparesis since 3 months
On examination:
Hypertonia in all four limbs
Hyperreflexia  particularly in knees
Gait: ataxic 
Rest CNS normal 
Looked for his neck movements and found a new sign: Inability to touch the chin to the chest but able to touch his occiput to the bed (negative Narketpally sign) 
Impression hypothesis:
Cervical OPLL as a  result of the prevalent elemental toxin          
https://youtu.be/it70h5mjEaw?is=8ZUhMSCugt0l_gsA
https://www.sciencedirect.com/topics/immunology-and-microbiology/vibration-sense        
[4:13 PM, 7/24/2026] cm: πŸ‘†@huai145 did this quick study in her batchmates using the protocol above and to everyone's surprise found that all of them had perception lower than normal!
[4:14 PM, 7/24/2026] cm:πŸ‘†We began to wonder if the tuning forks sent through Amazon were the culprit!
[4:33 PM, 7/24/2026] huai2: Joint position and movement more reliable
[9:08 PM, 7/24/2026] cm: We checked out this paperπŸ‘‡
Looks like 8 seconds is good enough, which is what the current intern batchmates demonstrated
Now we need to test the same on the great toe of all those individuals 
[8:05 PM, 7/26/2026] cm: Tomorrow's academics:
Student CPC
Venue: LT1
Time: 8-9 AM
Case 1: 
Aplastic Anemia with IC Bleed with pulmonary hemorrhage, refractory shock with respiratory failure
Clinical discussant: 
Dr. K. Bala Saraswathi
Pathology discussant:
Dr. Hannah
Clinical Incharge:
Dr Ankur
Case 2: 
Fever with sore throat for 9 days, swelling in the neck for 5 days, D/D: Strep TST, Diphtheria, DRESS Syndrome
Clinical discussant: 
Dr Sreepriya
Pathology discussant:
Dr. Sudipa
Clinical Incharge:
Dr Sanjay Verma
Chairperson:
Dr. Sunitha G
The session will be available on online webEx platform link details provided below. 
Thank you
[1.47 pm, 7/31/2026] huai144: What does this report says @huai147 ma'am?
She is a patient from West Bengal
[2:18 PM, 7/31/2026] huai147: Thrombocytopenia  definitely 
 Hb is less but l don't agree with erythrocyte morphology   at this MCV. .
[2:20 PM, 7/31/2026] huai144: Ohkk! Mam
[2:33 PM, 7/31/2026] cm: Ma'am what is your opinion on the possible reason for her thrombocytopenia given the MPV?
These were incidental findings on routine hemogram
[2:41 PM, 7/31/2026] huai147: Increased peripheral destruction  of platlet is leading to release of  early / immature platelets reflecting as High MPV
[2:41 PM, 7/31/2026] cm: Is this a usual finding in immune thrombocytopenia?
[2:42 PM, 7/31/2026] huai147: Yes sir
[3:10 PM, 7/31/2026] huai148: Start with common things
1. B12 and/or Folate deficiency with Iron deficiency 
2. ITP
3. Myelodysplasia
[3:14 PM, 7/31/2026] cm: Thanks Ma'am.
Agree. An increased mean platelet volume (MPV) is commonly observed in immune thrombocytopenia (ITP), while truly "giant" platelets are more characteristic of inherited macrothrombocytopenias.
Perhaps a further review of the patient's slide may tell us if they're truly giant platelets
[3:45 PM, 7/31/2026] huai147: A microscopic review is a must because large or giant platlets  are misinterpreted by the analyzer as RBC ..  so both the platelet and RBC values may be wrong.
[3:57 PM, 7/31/2026] huai144: Ok ma'am
[4:56 PM, 7/31/2026] cm: However in the context of this patient being from West Bengal, this could be a new disease that was first discovered in 2002 from Bengali long distance patients traveling to South Indian hospitals aka Bengal Macro thrombocytopenia first reported from CMC Vellore!πŸ‘‡
Later it was renamed Harris syndrome after the first author from CMC Vellore: 
The syndrome was subsequently developed further by pathologist, Kanjaksha Ghosh's team (later retired as ICMR director) who studied the differential expression of genes in Bengal macrothrombocytopenia (BMTCP) here: https://www.sciencedirect.com/science/article/abs/pii/S1079979615001710?via%3Dihub